SUN bioscience Revenue and Competitors
Estimated Revenue & Valuation
- SUN bioscience's estimated annual revenue is currently $2M per year.
- SUN bioscience's estimated revenue per employee is $155,000
Employee Data
- SUN bioscience has 13 Employees.
- SUN bioscience grew their employee count by -28% last year.
SUN bioscience's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Project Manager | Reveal Email/Phone |
2 | Process Quality Engineer | Reveal Email/Phone |
SUN bioscience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is SUN bioscience?
SUN bioscience is enabling personalized medicine through patient-specific organoids cultured on SUN's proprietary high-throughput 3D microwell platform. Organoids are self-organizing 3D miniature tissues with organ-mimicking functions that are grown from stem cells. They are powerful human in vitro models for assessing pharmaceutical efficacy and toxicity early on in drug development. The SUN technology is solving the problems that organoid culture today cannot be scaled and automated. This will introduce a new area of drug discovery where we can understand drug performance outside of an animal or a human being.
keywords:N/AN/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
-28%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SUN bioscience News
Economic development, industry leaders form coalition to drive bioscience growth in region. Sun., April 10, 2022. A group of economic development and...
An interview with MIT biologist David Sun Kongon science, activism, ... CEO of Mammoth Biosciencea synthetic biology startup specializing...
Atlanta's life sciences scene is in its infancy, but it has been among the Sun Belt markets to grow in prominence in recent years,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.6M | 13 | -7% | N/A |
#2 | $1.2M | 14 | -7% | N/A |
#3 | $2.3M | 14 | 0% | N/A |
#4 | $1.3M | 15 | N/A | N/A |
#5 | $2.4M | 15 | 0% | N/A |